Unites 3D beam sculpting, tomosynthesis image guidance, and automated motion tracking in a single, intelligent mobile unit to deliver directional and conformal radiation that pinpoints the tumor bed while protecting surrounding tissue—in under 20 minutes.
The cell and small animal X-ray irradiator purpose-built for researchers, by researchers—providing a simplified, sophisticated experience for all users.
A groundbreaking 500 kVp irradiator—developed in collaboration with top cancer research centers—to empower cell and small animal studies with unmatched precision, reliability and performance.
An innovative, oncology-focused, AI- and Monte Carlo-powered cloud OS that revolutionizes radiation physics, biological data analysis, and clinical workflows.
We are redefining oncology by fusing quantum physics, molecular biology, chemistry, and machine learning. This multidisciplinary approach drives innovation across three integrated divisions: Research & Clinical Devices, Therapeutics, and Informatics.
Learn More
We are harnessing the power of Al to deepen biological insight and accelerate the development of next-generation treatments and therapies.
To redefine therapeutic standards, our pipeline targets a broad spectrum of solid tumors, featuring novel candidates like an orally bioavailable TLR2 antagonist designed to combat aggressive cancers— including glioblastoma.
Learn MoreRadiation Therapy
Empyrean has entered into an exclusive license and joint development agreement with MD Anderson. Together, we aim to commercialize a groundbreaking magnetically optimized, very-high-energy electron therapy platform poised to elevate efficacy in radiation oncology.
Join us at the forefront of radiation oncology as we transform cancer care through breakthrough technologies that redefine precision, performance, and outcomes. Discover how your partnership will impact patients worldwide.
Learn More
Do you want to collaborate with world-class scientists, engineers, and innovators united by a mission to accelerate cancer treatment? Empyrean is seeking unconventional thinkers driven to make an impact in oncology.
Learn More